Pharmafile Logo
Pharmafocus logo
Advanced Search

Medidata partners with Circuit Clinical to strengthen clinical trial capabilities

January 27, 2022
Business Services

Medidata has announced a partnership with Circuit Clinical to strengthen its decentralised clinical trial (DCT) capabilities. Circuit Clinical has created …

News

FDA clearance of Investigational New Drug Application for novel peanut allergy vaccine

January 26, 2022
Research and Development

Allergy Therapeutics has announced the FDA clearance of the Investigational New Drug Application (IND) for its novel virus-like particle (VLP)-based …

News

Highest UK COVID-19 deaths since February as Pfizer begin trials for Omicron jab

January 26, 2022
Research and Development

Pfizer has begun clinical trials for its new COVID-19 vaccine tailored to the Omicron variant, and has shared that it …

News

Maxim Biomedical receives EUA for ClearDetect COVID-19 antigen home test

January 26, 2022
Research and Development

Maxim Biomedical have received an Emergency Use Authorisation (EUA) from the FDA for their new ClearDetect COVID-19 Antigen Home Test. …

News

New study highlights cell power as a functional biomarker for preventing tumour escape

January 26, 2022
Research and Development

LUMICKS announced that new research findings published in Translational Medicine detailed a novel design strategy for preventing tumour escape through …

News

FDA grants Evrysdi priority review for treatment of spinal muscular atrophy in infants

January 25, 2022
Manufacturing and Production

The FDA has granted priority review of a supplemental new drug application (sNDA) for Evrysdi (risdiplam), to expand the indication …

News
credit_-_crevis_shutterstock_340710245_720

Significantly reduced tumour growth with new candidate

January 25, 2022
Manufacturing and Production

Spago Nanomedical AB announced new clinical and preclinical results for the company’s leading candidate drug, Tumorad® (177Lu-SN201). In a preclinical …

News

Bimzelx approved in Japan for treatment of multiple types of psoriasis

January 25, 2022
Manufacturing and Production

UCB announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted marketing authorisation for BIMZELX (bimekizumab) for …

News

FDA restrict use of two monoclonal antibody treatments

January 25, 2022
Manufacturing and Production

The FDA has shared that it is limiting the use of two monoclonal antibody therapies for the treatment of COVID-19, …

News

Ascletis begins Phase III trial into bevacizumab for treatment of recurrent glioblastoma

January 24, 2022
Sales and Marketing

Ascletis Pharma has announced the dosing of the first patient in the Phase III registration clinical trial of ASC40, combined …

News

Pfizer: Annual COVID shots preferable to frequent boosters

January 24, 2022
Sales and Marketing

Pfizer CEO Albert Bourla has commented that an annual COVID-19 vaccine would be preferable to more frequent booster shots in …

News

NICE expands guidance for lokelma in adult patients with persistent hyperkalaemia

January 24, 2022
Sales and Marketing

NICE have updated the Technology Appraisal Guidance (TAG) for Lokelma (sodium zirconium cyclosilicate SZC) in the treatment of adult patients …

News

Veklury obtains FDA approval for COVID-19 outpatients

January 24, 2022
Sales and Marketing

The FDA has granted expedited approval of a supplemental new drug application (sNDA) for Veklury (remdesivir) for he treatment of …

News

EU health ministers consider fourth COVID-19 vaccine dose

January 21, 2022
Medical Communications

European Union health ministers will try to find a common line on Friday over a potential fourth dose of COVID-19 …

News

Amid plans to ease COVID restrictions, dialysis patients remain vulnerable to Omicron

January 21, 2022
Medical Communications

As the government in England relaxes COVID-19 restrictions, new data from the Francis Crick Institute raise concerns over the impact …

News

Artificial pancreas may prove life-changing for young children with diabetes

January 21, 2022
Medical Communications

Cambridge researchers have developed an artificial pancreas which may beat standard treatment in controlling Type 1 diabetes in young children. …

News

Clover reveals positive data from Phase II/III COVID-19 vaccine trial

January 21, 2022
Medical Communications

Clover Biopharmaceuticals has announced that final efficacy data from SPECTRA, a global Phase II/III clinical trial into its COVID-19 vaccine …

News

LUMAKRAS (sotorasib) receives approval in Japan for lung cancer patients

January 20, 2022
Business Services

Amgen has announced that LUMAKRAS received approval in Japan for the treatment of patients with KRAS G12C-mutated advanced non-small cell …

News

All Plan B restrictions to end in England

January 20, 2022
Business Services

Prime Minister Boris Johnson has announced that England’s Plan B measures are to end from 26 January. This will include …

News

1.27 million deaths a year attributable to antimicrobial resistance

January 20, 2022
Business Services

The Global Research on Antimicrobial Resistance (GRAM) paper has revealed the true scale of antibiotic resistance in Western Europe, and …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026